226 related articles for article (PubMed ID: 7550128)
1. Studies on the antiviral activity of protein kinase inhibitors against the replication of vesicular stomatitis virus.
Kim YS; Sagara J; Kawai A
Biol Pharm Bull; 1995 Jun; 18(6):895-9. PubMed ID: 7550128
[TBL] [Abstract][Full Text] [Related]
2. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus.
Kim YS; Kawai A
Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507
[TBL] [Abstract][Full Text] [Related]
3. KT5926, a potent and selective inhibitor of myosin light chain kinase.
Nakanishi S; Yamada K; Iwahashi K; Kuroda K; Kase H
Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635
[TBL] [Abstract][Full Text] [Related]
4. Concentration-dependent stimulation and inhibition of growth cone behavior and neurite elongation by protein kinase inhibitors KT5926 and K-252a.
Oberstar JV; Challacombe JF; Roche FK; Letourneau PC
J Neurobiol; 1997 Aug; 33(2):161-71. PubMed ID: 9240372
[TBL] [Abstract][Full Text] [Related]
5. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
Li J; Chorba JS; Whelan SP
J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
[TBL] [Abstract][Full Text] [Related]
6. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
Dargan DJ; Galt CB; Subak-Sharpe JH
J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
[TBL] [Abstract][Full Text] [Related]
7. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
Trottier MD; Palian BM; Reiss CS
Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
[TBL] [Abstract][Full Text] [Related]
8. Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State.
Kueck T; Bloyet LM; Cassella E; Zang T; Schmidt F; Brusic V; Tekes G; Pornillos O; Whelan SPJ; Bieniasz PD
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578292
[TBL] [Abstract][Full Text] [Related]
9. Restricted replication of vesicular stomatitis virus in T lymphocytes is coincident with a deficiency in a cellular protein kinase required for viral transcription.
Sleat DE; Chikkala NF; Gautam S; Banerjee AK
J Gen Virol; 1992 Dec; 73 ( Pt 12)():3125-32. PubMed ID: 1335023
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication.
Parker J; Ahrens PB; Ankel H
Antiviral Res; 1995 Jan; 26(1):83-96. PubMed ID: 7537950
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of anti-vesicular stomatitis virus activity of deazaneplanocin and its 3-brominated analogs.
Gibbons JS; Khadka S; Williams CG; Wang L; Schneller SW; Liu C; Tufariello JM; Basler CF
Antiviral Res; 2021 Jul; 191():105088. PubMed ID: 34019950
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells.
Borghi P; Di Marzio P; Varano B; Conti L; Belardelli F; Gessani S
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2949-54. PubMed ID: 1279103
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells.
Pica F; Rossi A; Santirocco N; Palamara A; Garaci E; Santoro MG
Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vesicular stomatitis virus replication in dexamethasone-treated L929 cells.
Lancz G; Whitaker-Dowling P; Marsh YV; Bradley G; Eppstein DA; Hackney JF; Hulick-Swardstrom B
Proc Soc Exp Biol Med; 1990 Mar; 193(3):190-6. PubMed ID: 2154755
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of the prostanoid clavulone II against vesicular stomatitis virus.
Bader T; Yamada Y; Ankel H
Antiviral Res; 1991 Dec; 16(4):341-55. PubMed ID: 1663734
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the phosphorylation of the regulatory non-structural protein of vesicular stomatitis virus by an antiviral xanthate compound.
Müller-Decker K; Amtmann E; Sauer G
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3045-56. PubMed ID: 2447222
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
[TBL] [Abstract][Full Text] [Related]
18. K-252a, a novel microbial product, inhibits smooth muscle myosin light chain kinase.
Nakanishi S; Yamada K; Kase H; Nakamura S; Nonomura Y
J Biol Chem; 1988 May; 263(13):6215-9. PubMed ID: 2966151
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells.
Romanutti C; Castilla V; Coto CE; Wachsman MB
Int J Antimicrob Agents; 2007 Mar; 29(3):311-6. PubMed ID: 17275263
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells.
Korutla L; Kumar R
Biochem Biophys Res Commun; 1996 Mar; 220(3):670-4. PubMed ID: 8607823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
